103 related articles for article (PubMed ID: 16203175)
1. Changes of selected hematologic parameters during long-term immunoadsorption therapy.
Pták J
Transfus Apher Sci; 2005 Nov; 33(3):299-304. PubMed ID: 16203175
[TBL] [Abstract][Full Text] [Related]
2. Immunoadsorption therapy and complement activation.
Pták J; Lochman J
Transfus Apher Sci; 2005 Jun; 32(3):263-7. PubMed ID: 15944112
[TBL] [Abstract][Full Text] [Related]
3. [Long-term treatment of refractory myasthenia gravis with immunoadsorption].
Wagner S; Janzen RW; Mohs C; Pohlmann S; Klingel R; Grützmacher PW
Dtsch Med Wochenschr; 2008 Nov; 133(46):2377-82. PubMed ID: 18988129
[TBL] [Abstract][Full Text] [Related]
4. Long-term effects of a multimodal approach including immunoadsorption for the treatment of myasthenic crisis.
Zeitler H; Ulrich-Merzenich G; Hoffmann L; Kornblum C; Schmidt S; Vetter H; Walger P
Artif Organs; 2006 Aug; 30(8):597-605. PubMed ID: 16911313
[TBL] [Abstract][Full Text] [Related]
5. The effect of double- and triple-apheresis platelet product donation on apheresis donor platelet and white blood cell counts.
Richa E; Krueger P; Burgstaler EA; Bryant SC; Winters JL
Transfusion; 2008 Jul; 48(7):1325-32. PubMed ID: 18346017
[TBL] [Abstract][Full Text] [Related]
6. Changes of plasma proteins after immunoadsorption using Ig-Adsopak columns in patients with myasthenia gravis.
Pták J
Transfus Apher Sci; 2004 Apr; 30(2):125-9. PubMed ID: 15062750
[TBL] [Abstract][Full Text] [Related]
7. [Immunoadsorption therapy for myasthenia gravis: study on the adsorption capacity of an immunoadsorption column].
Yeh JH; Chiu HC
J Microbiol Immunol Infect; 1999 Jun; 32(2):121-5. PubMed ID: 11565565
[TBL] [Abstract][Full Text] [Related]
8. [Efficacy of immunoadsorption therapy in the treatment of myasthenia gravis and the mechanism].
LI QL; XIE FH; LUO YS
Nan Fang Yi Ke Da Xue Xue Bao; 2011 Mar; 31(3):561-3. PubMed ID: 21421508
[TBL] [Abstract][Full Text] [Related]
9. Short-term and long-term intra-individual variations and critical differences of haematological laboratory parameters.
Costongs GM; Janson PC; Bas BM; Hermans J; Brombacher PJ; van Wersch JW
J Clin Chem Clin Biochem; 1985 Feb; 23(2):69-76. PubMed ID: 4039358
[TBL] [Abstract][Full Text] [Related]
10. Clinical efficacy and biocompatibility of three different leukocyte and fat removal filters during cardiac surgery.
de Vries AJ; Vermeijden WJ; Gu YJ; Hagenaars JA; van Oeveren W
Artif Organs; 2006 Jun; 30(6):452-7. PubMed ID: 16734597
[TBL] [Abstract][Full Text] [Related]
11. Effect of IgG immunoadsorption on serum cytokines in MG and LEMS patients.
Baggi F; Ubiali F; Nava S; Nessi V; Andreetta F; Rigamonti A; Maggi L; Mantegazza R; Antozzi C
J Neuroimmunol; 2008 Sep; 201-202():104-10. PubMed ID: 18644634
[TBL] [Abstract][Full Text] [Related]
12. [Haematological changes following long-term treatment of multiple sclerosis and myasthenia with azathioprin (author's transl)].
Haas J; Patzold U
Nervenarzt; 1982 Feb; 53(2):105-9. PubMed ID: 6801533
[No Abstract] [Full Text] [Related]
13. [Clinical and laboratory prognostic parameters for leukemic types of chronic lymphoproliferative diseases].
Kardum-Skelin I; Planinc-Peraica A; Ostojić Kolonić S; Radić-Kristo D; Milas M; Vrhovac R; Sustercić D; Minigo H; Jaksić B
Acta Med Croatica; 2008 Oct; 62(4):351-64. PubMed ID: 19205412
[TBL] [Abstract][Full Text] [Related]
14. [Red cell system and selected red cell enzymes in men occupationally exposed to mercury vapours].
Zabiński Z; Rutowski J; Moszczyński P; Dabrowski Z
Przegl Lek; 2006; 63 Suppl 7():74-83. PubMed ID: 17784549
[TBL] [Abstract][Full Text] [Related]
15. Effects of training and strenuous exercise on hematologic values and peripheral blood leukocyte subsets in racing sled dogs.
Davis MS; Davis WC; Ensign WY; Hinchcliff KW; Holbrook TC; Williamson KK
J Am Vet Med Assoc; 2008 Mar; 232(6):873-8. PubMed ID: 18341444
[TBL] [Abstract][Full Text] [Related]
16. Guillain-Barré syndrome treated by membrane plasma exchange and/or immunoadsorption.
Marn Pernat A; Buturović-Ponikvar J; Svigelj V; Ponikvar R
Ther Apher Dial; 2009 Aug; 13(4):310-3. PubMed ID: 19695065
[TBL] [Abstract][Full Text] [Related]
17. [Clinical study of double filtration plasmapheresis for treatment of refractory myasthenia gravis].
Huo JT; Long HL; Luo X; Xu JZ
Nan Fang Yi Ke Da Xue Xue Bao; 2007 Mar; 27(3):355-7. PubMed ID: 17425991
[TBL] [Abstract][Full Text] [Related]
18. Surgical outcome in thymic tumors with myasthenia gravis after plasmapheresis--a comparative study.
Sarkar BK; Sengupta P; Sarkar UN
Interact Cardiovasc Thorac Surg; 2008 Dec; 7(6):1007-10. PubMed ID: 18682429
[TBL] [Abstract][Full Text] [Related]
19. Alteration of platelet counts and lipid profiles after treatment of acute Plasmodium vivax.
Kim JS; Oh JS; Chang EA; Bae SY; Nam DH; Lee CH; Yang JH; Lee CK; Lee WJ; Kim HC; Klein TA; Lim CS; Kim YK
Acta Trop; 2008 Apr; 106(1):39-43. PubMed ID: 18304498
[TBL] [Abstract][Full Text] [Related]
20. Partial splenic embolization for hypersplenism in cirrhosis: a long-term outcome in 62 patients.
Zhu K; Meng X; Qian J; Huang M; Li Z; Guan S; Jiang Z; Shan H
Dig Liver Dis; 2009 Jun; 41(6):411-6. PubMed ID: 19070555
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
